Söndag 15 November | 05:05:50 Europe / Stockholm
Est. tid*
2027-10-26 08:00 Kvartalsrapport 2027-Q3
2027-08-17 08:00 Kvartalsrapport 2027-Q2
2027-04-27 08:00 Kvartalsrapport 2027-Q1
2027-02-23 18:30 Bokslutskommuniké 2026
2026-11-05 - Kvartalsrapport 2026-Q3
2026-08-20 - Kvartalsrapport 2026-Q2
2026-05-08 - X-dag ordinarie utdelning MCLR 0.00 SEK
2026-05-07 - Kvartalsrapport 2026-Q1
2026-04-22 - Årsstämma
2026-02-19 - Bokslutskommuniké 2025
2025-11-06 - Kvartalsrapport 2025-Q3
2025-08-21 - Kvartalsrapport 2025-Q2
2025-05-09 - X-dag ordinarie utdelning MCLR 0.00 SEK
2025-05-08 - Kvartalsrapport 2025-Q1
2025-04-16 - Årsstämma
2025-02-28 - Bokslutskommuniké 2024
2024-11-07 - Kvartalsrapport 2024-Q3
2024-08-09 - Kvartalsrapport 2024-Q2
2024-05-14 - Kvartalsrapport 2024-Q1
2024-04-19 - X-dag ordinarie utdelning MCLR 0.00 SEK
2024-04-18 - Årsstämma
2024-02-28 - Bokslutskommuniké 2023
2023-11-02 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-05-11 - Årsstämma
2023-05-11 - X-dag ordinarie utdelning MCLR 0.00 SEK
2023-05-10 - Kvartalsrapport 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-11-03 - Kvartalsrapport 2022-Q3
2022-08-11 - Kvartalsrapport 2022-Q2
2022-05-05 - Kvartalsrapport 2022-Q1
2022-04-07 - X-dag ordinarie utdelning MCLR 0.00 SEK
2022-04-06 - Årsstämma
2022-02-23 - Bokslutskommuniké 2021
2021-08-19 - Kvartalsrapport 2021-Q2
2021-06-02 - X-dag ordinarie utdelning MCLR 0.00 SEK
2021-03-03 - Extra Bolagsstämma 2021
2021-02-23 - Bokslutskommuniké 2020
2020-08-19 - Kvartalsrapport 2020-Q2
2020-06-11 - X-dag ordinarie utdelning MCLR 0.00 SEK
2020-06-10 - Årsstämma
2020-02-21 - Bokslutskommuniké 2019
2019-08-22 - Kvartalsrapport 2019-Q2
2019-05-22 - X-dag ordinarie utdelning MCLR 0.00 SEK
2019-05-21 - Årsstämma
2018-08-23 - Kvartalsrapport 2018-Q2
2018-05-17 - X-dag ordinarie utdelning MCLR 0.00 SEK
2018-05-16 - Årsstämma
2018-02-16 - Bokslutskommuniké 2017
2017-08-25 - Kvartalsrapport 2017-Q2
2017-05-19 - X-dag ordinarie utdelning MCLR 0.00 SEK
2017-05-18 - Årsstämma
LandSverige
ListaNordic SME Sweden
SektorHandel & varor
IndustriSällanköpsvaror
Medclair är ett svenskt cleantech-bolag som utvecklar teknik för hållbar hantering av lustgas inom sjukvård, återvinningsindustri och andra branscher med lustgasanvändning. Bolaget har en etablerad internationell närvaro och erbjuder lösningar som ämnar till att både minska klimatpåverkan och förbättra arbetsmiljön. Huvudkontoret finns beläget i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

New legislation in California creates business opportunities for Medclair

2026-11-11 08:00:00

On January 1, 2027, a new nitrous oxide law will take effect in California, which is expected to increase the need for the safe management and destruction of confiscated nitrous oxide canisters. Medclair has already engaged in concrete dialogues with state authorities and sees opportunities to establish its technology in the US market. The initiative is a further step in the company's expansion in North America, where Medclair also recently announced a strategic Letter of Intent (LOI) with a major international industrial player.

The new legislation restricts the sale and distribution of certain nitrous oxide products. During a recent market visit, Medclair engaged in dialogues with state authorities in California seeking solutions for the management and destruction of confiscated and abandoned nitrous oxide canisters. The combination of a growing regulatory need, concrete customer dialogues, and the company's experience from similar operations in Europe creates favorable conditions for establishing a presence in the US market.

Concurrently, Medclair has identified interest within Healthcare and Dental. Together with the recently announced LOI, which concerns the development and commercialization of products based on the company's new technology platform, this strengthens the prospects for a broader establishment in the North American market.

“We see a growing interest in our technology in North America. The new legislation in California creates concrete business opportunities, while our recently announced LOI paves the way for broader commercialization. Our ambition is to gradually establish customer relationships and build an installed base across our three business areas. This creates conditions for both upselling and growing recurring revenues”, says Jonas Lundh, CEO of Medclair.

Jonas Lundh CEO Medclair AB